Thyroid Scintigraphy
Thyroid scintigraphy using Tc-99m pertechnetate or I-123 provides functional thyroid imaging; it identifies 'hot' (hyperfunctioning) nodules, differentiates Graves' disease from toxic multinodular goitre, and is used for RAI treatment dose calculation.
Thyroid Scintigraphy is frequently researched by patients in thyroid and parathyroid surgery, yet the search term alone is not enough to settle personal care. Thyroid scintigraphy using Tc-99m pertechnetate or I-123 provides functional thyroid imaging; it identifies 'hot' (hyperfunctioning) nodules, differentiates Graves' disease from toxic multinodular goitre, and is used for RAI treatment dose calculation. Age, comorbidities, this entry side pattern, duration and previous report language change the clinical reading. the clinical point assessment interprets neck examination, the dictionary entry nodule behavior, this topic hormone balance, this term vocal fold mobility and the finding family history together. This entry uses a function-first way of assessing this entry and points to the questions worth preparing. For the clinical point, the existing summary aims to connect the reported complaint with examination findings: Per EANM 2013 guidelines, scintigraphy is indicated for assessing hyperfunctioning in patients with a TSH-suppressed nodule (TSH <0.4 mIU/L). The topic is therefore read with clinical context, not as a one-line definition.
During a the clinical point consultation, the patient's description is compared with the examination finding. The the dictionary entry onset date, progression pattern, side difference, quality-of-life effect and prior treatment response are recorded. this topic review may combine ultrasound findings, this term laboratory results, the finding fine-needle biopsy and this entry laryngoscopic vocal fold assessment when useful. the clinical point decisions weigh nodule size, the dictionary entry ultrasound pattern, this topic lymph-node appearance, this term prior biopsy result and the dictionary entry risk profile separately. In this topic, the clinical aim is to prove the finding that explains the complaint and separate similar-looking conditions: Tc-99m pertechnetate reflects uptake without organification within 20 minutes; I-123 provides true 24-hour uptake measurement. Tests are requested when they help make that distinction. Diagnosis therefore rests on the whole clinical picture rather than one report sentence.
this term care translates diagnosis into a practical pathway. Safety boundaries, functional loss, recovery time, possible complications and review needs are discussed in the same visit. the finding planning discusses observation, this entry medical adjustment, the clinical point lobectomy-total thyroidectomy, the dictionary entry parathyroid strategy or this topic neck dissection by findings. Management of this term is individualized according to symptom duration, examination findings, functional impact, patient expectations, prior treatment response and imaging or laboratory results when needed. Balanced planning for this topic reduces avoidable delay and unnecessary intervention.
Review of the finding compares the baseline finding with the current this topic complaint using the same scale. this term follow-up reviews calcium balance, the finding voice quality, this entry wound healing, the clinical point pathology results and the dictionary entry hormone replacement together. Safe communication about this topic helps patients notice risky symptoms early without increasing anxiety and supports adherence to follow-up advice. If this term develops the finding context with rapidly growing neck mass, new hoarseness or breathing-swallowing pressure, review is brought forward.
Before the this entry visit, the patient can arrange onset date, side pattern, previous tests and medication history in a short sequence; consultation time can then focus on personal risk and care choices.
When planning the note, this term context: safety interpretation is left to personal examination; appointment time is used with less friction.
In the patient file, the finding context: older tests are compared with the current complaint; general information does not become a personal decision; For terminology clarity, thyroid patient question stay in the same context.
Indications and Technique
Primary indications: (1) TSH-suppressed (<0.4 mIU/L) nodule — hot/cold differentiation; (2) differentiation of Graves' disease from toxic multinodular goitre; (3) postoperative DTC residual/metastasis evaluation; (4) uptake measurement before RAI dose. Tc-99m pertechnetate is administered IV; imaging is performed 20–30 minutes later with a gamma camera. I-123 is given orally; early (4–6h) and late (24h) images are acquired. Normal thyroid I-123 24h uptake: 15–35%.
Management Based on Scintigraphic Findings
Hot nodule: RAI or surgery (toxic adenoma). Diffusely increased uptake with homogeneous distribution: Graves' disease → antithyroid drug, RAI, or surgery. Heterogeneously increased uptake with multiple hot areas: toxic multinodular goitre → RAI or surgery. Cold nodule: US + FNA mandatory. Postoperative whole-body scintigraphy: RAI ablation is planned if residual tissue is found; metastasis is localised.
When to Seek Care
Patients with TSH-suppressed nodules, symptoms of hyperthyroidism, or requiring post-DTC surveillance should consult nuclear medicine or endocrinology. In pregnant women and nursing mothers, all radioactive imaging must be replaced with alternatives.
Frequently asked questions
What is Thyroid Scintigraphy?
When is Thyroid Scintigraphy clinically important?
When is ENT assessment relevant for Thyroid Scintigraphy?
What information helps assessment of Thyroid Scintigraphy?
Learn more about this procedure
Detailed guide from Prof. Dr. Özdoğan's clinic
Related terms
References
This glossary entry is for informational purposes only and does not constitute medical advice. Consult a qualified specialist for diagnosis and treatment.